Video

Ascend & ABL Inc. Capacity Update October 2025: Cell & Gene Therapy

Ascend-ABL is a leading CDMO specializing in the development and manufacture of advanced therapies, offering one of the industry's most comprehensive viral vector capabilities—including AAV, lentiviral vectors, oncolytics, immunotherapies, and vaccines.

Operating from state-of-the-art GMP facilities, we provide end-to-end services to commercial, academic, and government clients, spanning process innovation through development, GMP manufacturing, QC testing, to aseptic fill/finish.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Ascend & ABL Inc.